CytomX Therapeutics
CTMX
#9040
Rank
ยฃ68.04 M
Marketcap
ยฃ0.87
Share price
0.00%
Change (1 day)
-25.54%
Change (1 year)

Revenue for CytomX Therapeutics (CTMX)

Revenue in 2024 (TTM): ยฃ98.55 Million

According to CytomX Therapeutics 's latest financial reports the company's current revenue (TTM ) is ยฃ0.10 Billion. In 2023 the company made a revenue of ยฃ79.44 Million an increase over the revenue in the year 2022 that were of ยฃ28.09 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for CytomX Therapeutics from 2015 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ98.55 M24.05%
2023 ยฃ79.44 M182.8%
2022 ยฃ28.09 M-45.5%
2021 ยฃ51.54 M-30%
2020 ยฃ73.62 M67.95%
2019 ยฃ43.84 M-6.47%
2018 ยฃ46.87 M-11.55%
2017 ยฃ52.99 M334.69%
2016 ยฃ12.19 M134.27%
2015 ยฃ5.2 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA